CRISPR Therapeutics AG(CRSP)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CRSP CRISPR Therapeutics AG

交易中 11-22 09:51:47 EST

46.36

+0.07

+0.16%

最高46.79	最低45.85	成交量16.25万
今开46.28	昨收46.29	日振幅2.03%
总市值39.57亿	流通市值38.91亿	总股本8,535万
成交额752.05万	换手率0.19%	流通股本8,393万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"CRSP","market":"US","secType":"STK","nameCN":"CRISPR Therapeutics AG","latestPrice":46.3639,"timestamp":1732287107079,"preClose":46.29,"halted":0,"volume":162542,"delay":0,"floatShares":83933666,"shares":85353479,"eps":-2.896928,"marketStatus":"交易中","marketStatusCode":2,"change":0.0739,"latestTime":"11-22 09:51:47 EST","open":46.28,"high":46.7899,"low":45.85,"amount":7520492.280748,"amplitude":0.020305,"askPrice":46.42,"askSize":88,"bidPrice":46.25,"bidSize":224,"shortable":3,"etf":0,"ttmEps":-2.896928,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1732309200000},"adr":0,"listingDate":1476849600000,"adjPreClose":46.29,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":46.28,"preClose":46.29,"latestTime":"09:29 EST","volume":7794,"amount":361650.617658,"timestamp":1732285799999},"postHourTrading":{"tag":"盘后","latestPrice":46.7853,"preClose":46.29,"latestTime":"19:59 EST","volume":17451,"amount":809359.7072,"timestamp":1732237178487},"volumeRatio":1.340952,"impliedVol":0.5765,"impliedVolPercentile":0.2817},"requestUrl":"/m/hq/s/CRSP","defaultTab":"news","newsList":[{"id":"2484939491","title":"【华安证券·金融工程】专题报告：价格波动性与信息含量","url":"https://stock-news.laohu8.com/highlight/detail?id=2484939491","media":"市场投研资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484939491?lang=zh_cn&edition=full","pubTime":"2024-11-19 08:00","pubTimestamp":1731974400,"startTime":"0","endTime":"0","summary":"作者研究了金融市场中价格波动性与信息含量之间的均衡关系，旨在揭示通过观察价格波动性能够推断的信息含量。作者的实证研究结果表明，大多数股票表现出价格信息度与价格波动性之间的负共动。实际上，作者的结果意味着，价格波动性更大的股票往往信息度更低，反之亦然。一个易于计算且持续受到关注的替代均衡对象是价格波动性。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2024-11-19/doc-incwpyiy3109882.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2024-11-19/doc-incwpyiy3109882.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4588","CCM","BK4503","LU1861558580.USD","BK4196","LU1861559042.SGD","BK4139","BK4556","BK4585","CRSP"],"gpt_icon":0},{"id":"2483833270","title":"Crispr Therapeutics Ag盘中异动 急速下跌5.03%报47.29美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483833270","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483833270?lang=zh_cn&edition=full","pubTime":"2024-11-15 04:44","pubTimestamp":1731617049,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日04时44分，Crispr Therapeutics Ag股票出现异动，股价急速下挫5.03%。截至发稿，该股报47.29美元/股，成交量129.063万股，换手率1.51%，振幅5.56%。Crispr Therapeutics Ag股票所在的生物技术行业中，整体跌幅为1.93%。Crispr Therapeutics Ag公司简介：Crispr Therapeutics是一家基因编辑公司，专注于开发基于CRISPR/Cas9的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115044409abc21355&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115044409abc21355&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1861558580.USD","CRSP","BK4139","BK4588","BK4585","LENZ","LU1861559042.SGD","BK4556"],"gpt_icon":0},{"id":"2482738538","title":"Crispr Therapeutics Ag盘中异动 早盘股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482738538","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482738538?lang=zh_cn&edition=full","pubTime":"2024-11-11 22:34","pubTimestamp":1731335698,"startTime":"0","endTime":"0","summary":"北京时间2024年11月11日22时34分，Crispr Therapeutics Ag股票出现异动，股价大幅上涨5.00%。截至发稿，该股报54.20美元/股，成交量13.0852万股，换手率0.15%，振幅2.21%。Crispr Therapeutics Ag股票所在的生物技术行业中，整体跌幅为0.18%。Crispr Therapeutics Ag公司简介：Crispr Therapeutics是一家基因编辑公司，专注于开发基于CRISPR/Cas9的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111223459971a5b18&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111223459971a5b18&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","LU1861558580.USD","LU1861559042.SGD","BK4139","LENZ","BK4556","BK4585","CRSP"],"gpt_icon":0},{"id":"2481990482","title":"athie Wood布局新一轮科技热潮——白宫谁胜出都无关紧要","url":"https://stock-news.laohu8.com/highlight/detail?id=2481990482","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481990482?lang=zh_cn&edition=full","pubTime":"2024-11-07 08:11","pubTimestamp":1730938264,"startTime":"0","endTime":"0","summary":"ARK Invest的Cathie Wood正在为一个支持变革性技术的白宫政府布局。这位公司首席执行官兼首席投资官认为，无论谁赢得总统大选，较少的监管将引发一场科技热潮。去年上涨了近68%的ARK Innovation ETF在2024年下跌了约8%。自拜登总统上任以来，该基金也大幅下滑。ARKK持有的科技公司尤其对利率上升敏感。Wood认为，这种不佳表现只是暂时的。“CRISPR Therapeutics和Beam Therapeutics等公司已经开发出了治愈疾病的方法，”Wood表示。CRISPR在过去一个月上涨了11%，而Beam上涨了2%。ARK Genomic Revolution ETF持有这两只股票。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/11/07081145019009.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["BK4505","LU1914381329.SGD","ARKG","BK4533","LU1720051017.SGD","ARKK","LU0082616367.USD","BK4555","LU0964807845.USD","BK4534","LU0943347566.SGD","LU1861215975.USD","BK4511","LU0820561909.HKD","LU0198837287.USD","LU1839511570.USD","IE00BSNM7G36.USD","LU2213496289.HKD","FDN","LU2357305700.SGD","IE00BJLML261.HKD","LU2249611893.SGD","LU1435385759.SGD","CRSP","LU0234572021.USD","LU1429558221.USD","LU1861220033.SGD","LU2326559502.SGD","TSLA","SG9999015945.SGD","LU0719512351.SGD","LU1551013425.SGD","BK4574","BK4581","BK4527","LU0820562030.AUD","LU1720051108.HKD","LU1629891620.HKD","LU0316494557.USD","BK4099","IE00B1XK9C88.USD","BK4548","LU1852331112.SGD","BEAM","BK4139","LU0466842654.USD","BK4535","LU0234570918.USD","LU2023250330.USD","LU2063271972.USD"],"gpt_icon":1},{"id":"2481958207","title":"Crispr Therapeutics Ag2024财年第三财季实现净利润-85.94百万美元，同比增加23.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481958207","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481958207?lang=zh_cn&edition=full","pubTime":"2024-11-07 04:01","pubTimestamp":1730923319,"startTime":"0","endTime":"0","summary":"11月7日，Crispr Therapeutics Ag公布财报，公告显示公司2024财年第三财季净利润为-85.94百万美元，同比增加23.27%；其中营业收入为602000.00美元，每股基本收益为-1.01美元。从资产负债表来看，Crispr Therapeutics Ag总负债3.16亿美元，其中短期债务16.88百万美元，资产负债比为7.14，流动比率为0.22。机构评级：截至2024年11月7日，当前有25家机构对Crispr Therapeutics Ag目标价做出预测，其中目标均价为80.48美元，其中最低目标价为30.00美元，最高目标价为199.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107040201a21dc044&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107040201a21dc044&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","CRSP"],"gpt_icon":0},{"id":"2481688621","title":"Crispr Therapeutics Ag盘中异动 早盘股价大跌5.24%报47.94美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481688621","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481688621?lang=zh_cn&edition=full","pubTime":"2024-11-05 22:34","pubTimestamp":1730817247,"startTime":"0","endTime":"0","summary":"北京时间2024年11月05日22时34分，Crispr Therapeutics Ag股票出现波动，股价急速下挫5.24%。截至发稿，该股报47.94美元/股，成交量8.7367万股，换手率0.10%，振幅2.84%。Crispr Therapeutics Ag股票所在的生物技术行业中，整体涨幅为0.01%。Crispr Therapeutics Ag公司简介：Crispr Therapeutics是一家基因编辑公司，专注于开发基于CRISPR/Cas9的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105223407971a46e6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105223407971a46e6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1861558580.USD","BK4139","CRSP","LENZ","BK4588","LU1861559042.SGD","BK4585","BK4556"],"gpt_icon":0},{"id":"2481598463","title":"周期、估值与人性，新股民“财富增值”的关键指标丨书评","url":"https://stock-news.laohu8.com/highlight/detail?id=2481598463","media":"万有岛","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481598463?lang=zh_cn&edition=full","pubTime":"2024-11-05 08:10","pubTimestamp":1730765414,"startTime":"0","endTime":"0","summary":"文丨YSL*股市长线法宝第6版，[美]杰米里·西格尔，中信出版集团01 给你一张过去的折线图股票（包括权益型基金）投资者可能都会对《股市长线法宝》的名字有些印象，因为许多教你炒股、买基金的书里都会引用下面这张图（见图1），似乎不拉出一个200年的数据就没有说服力。*图1 1802—2002年真实全收益走势这张图看多了，我们...","market":"hk","thumbnail":"https://inews.gtimg.com/om_ls/OpJjVpv9786mYM-qeL8WZwCFBwMJV9uCtbjnjzL-oNmqUAA_294195/0","type":0,"news_type":0,"thumbnails":["https://inews.gtimg.com/om_ls/OpJjVpv9786mYM-qeL8WZwCFBwMJV9uCtbjnjzL-oNmqUAA_294195/0"],"rights":{"source":"tencent_tech","url":"https://new.qq.com/rain/a/20241105A012C300","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.author, .pubtime{#sourceStyle#; display: inline-block;} .pubtime{margin-left: 3px;}strong{font-weight:500;#lv2TextColor#}","selectors":".main-wrapper","filters":".follow_top, .channel-entry, .collapseWrapper, .pic, .gap, .showDividingLine, .loader, .container, .ct-sumary, .nav, .landad, .hairline-top, .footer, .recommend-modules, .headroom-wrapper, .elevator","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://new.qq.com/rain/a/20241105A012C300","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent_tech","symbols":["LU1430594728.SGD","LU1883839398.USD","LU1880398471.USD","LU1778281490.HKD","LU1585245621.USD","BK4538","BK4533","LU0868494617.USD","BK4579","IBM","LU1674673428.USD","BK4534","CRSP","BK4139","BK4588","BK4556","BK4585","LU0321505868.SGD","BK4134","LU0321505439.SGD","LU1861559042.SGD","BK4575","LU1880398554.USD","LU1861558580.USD","LU1674673691.USD"],"gpt_icon":0},{"id":"2480881263","title":"Crispr Therapeutics Ag盘中异动 大幅上涨5.13%报48.77美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480881263","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480881263?lang=zh_cn&edition=full","pubTime":"2024-11-01 21:58","pubTimestamp":1730469491,"startTime":"0","endTime":"0","summary":"北京时间2024年11月01日21时58分，Crispr Therapeutics Ag股票出现波动，股价快速拉升5.13%。截至发稿，该股报48.77美元/股，成交量21.4175万股，换手率0.25%，振幅3.84%。Crispr Therapeutics Ag股票所在的生物技术行业中，整体涨幅为0.70%。Crispr Therapeutics Ag公司简介：Crispr Therapeutics是一家基因编辑公司，专注于开发基于CRISPR/Cas9的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101215811ab92dcfd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101215811ab92dcfd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","LU1861559042.SGD","BK4556","LENZ","LU1861558580.USD","CRSP","BK4585","BK4139"],"gpt_icon":0},{"id":"2478481311","title":"Crispr Therapeutics Ag盘中异动 早盘股价大涨5.02%报49.74美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478481311","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478481311?lang=zh_cn&edition=full","pubTime":"2024-10-28 21:52","pubTimestamp":1730123566,"startTime":"0","endTime":"0","summary":"北京时间2024年10月28日21时52分，Crispr Therapeutics Ag股票出现异动，股价快速上涨5.02%。截至发稿，该股报49.74美元/股，成交量20.9268万股，换手率0.25%，振幅4.12%。Crispr Therapeutics Ag股票所在的生物技术行业中，整体涨幅为0.59%。Crispr Therapeutics Ag公司简介：Crispr Therapeutics是一家基因编辑公司，专注于开发基于CRISPR/Cas9的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028215246971a2a7e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028215246971a2a7e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","LU1861558580.USD","LU1861559042.SGD","BK4556","CRSP","BK4585","BK4588"],"gpt_icon":0},{"id":"2477577865","title":"Crispr Therapeutics Ag盘中异动 下午盘快速跳水5.02%报45.63美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477577865","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477577865?lang=zh_cn&edition=full","pubTime":"2024-10-24 02:19","pubTimestamp":1729707575,"startTime":"0","endTime":"0","summary":"北京时间2024年10月24日02时19分，Crispr Therapeutics Ag股票出现异动，股价急速下跌5.02%。截至发稿，该股报45.63美元/股，成交量108.13万股，换手率1.27%，振幅4.83%。Crispr Therapeutics Ag股票所在的生物技术行业中，整体跌幅为1.69%。Crispr Therapeutics Ag公司简介：Crispr Therapeutics是一家基因编辑公司，专注于开发基于CRISPR/Cas9的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241024021935ab6e00ed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241024021935ab6e00ed&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","LU1861558580.USD","BK4585","BK4556","LENZ","CRSP","LU1861559042.SGD","BK4139"],"gpt_icon":0},{"id":"2470781513","title":"更新版 4-辉瑞公司因镰状细胞病治疗存在并发症和死亡风险而撤销该产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2470781513","media":"路透中文","labels":["Product Release"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470781513?lang=zh_cn&edition=full","pubTime":"2024-09-26 05:10","pubTimestamp":1727298645,"startTime":"0","endTime":"0","summary":"更新版 4-辉瑞公司因镰状细胞病治疗存在并发症和死亡风险而撤销该产品第9段增加了欧洲药品管理局议程，第12段增加了其他治疗方法。路透9月26日 - 美国制药商辉瑞PFE.N周三表示，将从所有获批的镰状细胞病治疗药物Oxbryta市场撤出该药物，理由是该药物存在引起疼痛的并发症和死亡的风险。辉瑞表示将进一步审查现有数据，并已向监管机构通报了审查结果。辉瑞公司表示，预计撤销该项目不会影响其2024年的财务前景。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"31475a2f05bb5a0cf2e7acfeae2c0e13","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20240925:nL4T3L71O6:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"Product Release","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4534","BK4550","IE00BLSP4239.USD","LU0225771236.USD","SGXZ57979304.SGD","SG9999013999.USD","LU0289739699.SGD","LU1861559042.SGD","BK4568","SG9999003800.SGD","BLUE","CRSP","LU0225284248.USD","LU0321505868.SGD","LU0321505439.SGD","LU1066051498.USD","BK4592","IE00B19Z3B42.SGD","LU1894683264.USD","LU0868494617.USD","IE00BBT3K403.USD","LU0306807586.USD","LU1066053197.SGD","BK4578","LU1861558580.USD","SG9999002224.SGD","LU1894683348.USD","SG9999001176.SGD","BK4139","SG9999011175.SGD","IE00B19Z3581.USD","BK4585","LU0058720904.USD","IE0002270589.USD","LU0985481810.HKD","LU1883839398.USD","LU0122379950.USD","LU0170899867.USD","LU0234572021.USD","BK4533","IE00BLSP4452.SGD","LU0456855351.SGD","LU1057294990.SGD","PFE","SG9999002232.USD","BK4588","LU1023059063.AUD","SG9999001176.USD","BK4556","BK4581"],"gpt_icon":1},{"id":"2468392366","title":"Crispr Therapeutics Ag盘中异动 早盘急速上涨5.04%报50.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2468392366","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468392366?lang=zh_cn&edition=full","pubTime":"2024-09-17 23:24","pubTimestamp":1726586662,"startTime":"0","endTime":"0","summary":"北京时间2024年09月17日23时24分，Crispr Therapeutics Ag股票出现异动，股价大幅拉升5.04%。截至发稿，该股报50.15美元/股，成交量50.9706万股，换手率0.60%，振幅4.27%。Crispr Therapeutics Ag股票所在的生物技术行业中，整体跌幅为0.83%。Crispr Therapeutics Ag公司简介：Crispr Therapeutics是一家基因编辑公司，专注于开发基于CRISPR/Cas9的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024091723242298e37cf2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024091723242298e37cf2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1861559042.SGD","BK4585","CRSP","BK4588","LU1861558580.USD","BK4556","LENZ","BK4139"],"gpt_icon":0},{"id":"1179497928","title":"Fulcrum Therapeutics洛司马匹德三期临床试验失利，股价重挫逾60%","url":"https://stock-news.laohu8.com/highlight/detail?id=1179497928","media":"华尔街洞察","labels":["analysis"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1179497928?lang=zh_cn&edition=full","pubTime":"2024-09-13 08:20","pubTimestamp":1726186800,"startTime":"0","endTime":"0","summary":"纳斯达克上市公司$Fulcrum Therapeutics$, Inc.今日股价暴跌超过60%,主要原因是其主导候选药物洛司马匹德未能在治疗肌肉营养不良症的关键三期临床试验REACH中达到预期目标。根据Fulcrum发布的声明,REACH试验未能达到评估肌肉力量恢复的主要终点指标,次要终点指标也未达到显著性水平。Fulcrum CEO Alex C. Sapir表示,鉴于这些不利结果,公司将暂停洛司马匹德在FSHD适应证的进一步开发。这对Fulcrum无疑是一个重大打击。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"analysis","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LU1883839398.USD","BLUE","LU2237443978.SGD","LU0648001328.SGD","VRTX","LU0070302665.USD","LENZ","03347","LU2456880835.USD","SCD","PRO","LU2237443465.HKD","BK4207","LU1066053197.SGD","BK4556","LU0208291251.USD","SGXZ57979304.SGD","MFI","IE00B2B36J28.USD","LU0079474960.USD","BK1583","BK4581","03165","BK4007","IE00BJJMRZ35.SGD","IE00BKVL7J92.USD","BK4552","LU2237443549.SGD","LU0889565916.HKD","LU1201861165.SGD","BK4550","SNY","BAC","LU1668664300.SGD","FULC","RHHBY","LU0234570918.USD","BK1141","LU1861558580.USD","BK4127","LU1366192091.USD","LU1093756325.SGD","LU1718418525.SGD","PFE","BK1576","BK4568","CRSP","LU1093756168.USD","LU0130102774.USD","RNA","LU2462157665.USD","IE00BFTCPJ56.SGD","LU0170899867.USD","LU2237443622.USD","IE00B7SZLL34.SGD","BK4505"],"gpt_icon":0},{"id":"2461200533","title":"Crispr Therapeutics Ag盘中异动 临近收盘快速下跌5.05%报47.47美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2461200533","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461200533?lang=zh_cn&edition=full","pubTime":"2024-08-23 03:53","pubTimestamp":1724356397,"startTime":"0","endTime":"0","summary":"北京时间2024年08月23日03时53分，Crispr Therapeutics Ag股票出现异动，股价大幅下跌5.05%。截至发稿，该股报47.47美元/股，成交量87.9027万股，换手率1.03%，振幅4.99%。Crispr Therapeutics Ag股票所在的生物技术行业中，整体涨幅为0.09%。Crispr Therapeutics Ag公司简介：Crispr Therapeutics是一家基因编辑公司，专注于开发基于CRISPR/Cas9的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082303531798e35e8b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082303531798e35e8b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4556","BK4585","LENZ","LU1861558580.USD","CRSP","LU1861559042.SGD","BK4588"],"gpt_icon":0},{"id":"2459410239","title":"Crispr Therapeutics Ag盘中异动 股价大跌5.00%报45.81美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459410239","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459410239?lang=zh_cn&edition=full","pubTime":"2024-08-15 00:24","pubTimestamp":1723652649,"startTime":"0","endTime":"0","summary":"北京时间2024年08月15日00时24分，Crispr Therapeutics Ag股票出现异动，股价大幅跳水5.00%。截至发稿，该股报45.81美元/股，成交量89.7807万股，换手率1.05%，振幅5.35%。Crispr Therapeutics Ag股票所在的生物技术行业中，整体涨幅为0.17%。Crispr Therapeutics Ag公司简介：Crispr Therapeutics是一家基因编辑公司，专注于开发基于CRISPR/Cas9的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081500240997198be2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081500240997198be2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4556","BK4588","LU1861559042.SGD","BK4585","LU1861558580.USD","BK4139","CRSP"],"gpt_icon":0},{"id":"2459718409","title":"Illumina 与 CRISPR 先驱 Broad 研究所合作开发新型基因测序试剂盒","url":"https://stock-news.laohu8.com/highlight/detail?id=2459718409","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459718409?lang=zh_cn&edition=full","pubTime":"2024-08-14 01:01","pubTimestamp":1723568466,"startTime":"0","endTime":"0","summary":"    路透8月13日 - Illumina公司  周二表示，该公司已与布罗德研究所合作开发新的试剂盒，利用一种基于诺贝尔奖得主CRISPR技术的新方法进行大规模基因测序。为何重要 Illumina与CRISPR研究领域最著名的马萨诸塞州布罗德研究所合作，旨在使用一种名为PerturbSeq筛选的新方法来扩大基因测序量。这将有助于疾病和治疗研究，并推动 Illumina 的发展。Illumina 希望新技术的合作伙伴关系能为公司带来所需的推动力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ILMN","BK4556","BK4534","BK4588","LU1861559042.SGD","BK4585","BK4535","BK4139","LU1861558580.USD","BK4548","CRSP","BK4121"],"gpt_icon":0},{"id":"2457666802","title":"英国国家医疗服务系统将推出治疗罕见血液病的 Vertex/CRISPR 基因疗法","url":"https://stock-news.laohu8.com/highlight/detail?id=2457666802","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457666802?lang=zh_cn&edition=full","pubTime":"2024-08-08 07:28","pubTimestamp":1723073310,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    路透8月7日 - 英国国家医疗服务(NHS) Vertex公司周三在一份声明中说，该公司将开始推广Vertex制药公司  和CRISPR Therapeutics公司  治疗罕见血液病β地中海贫血症的基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z3581.USD","IE00B4R5TH58.HKD","LU1093756168.USD","IE0002141913.USD","IE00BJT1NW94.SGD","LU0417517546.SGD","LU1861558580.USD","BK4567","VERX","IE00B2B36J28.USD","LU1861559042.SGD","LU2362540622.SGD","BK4532","LU0823416689.USD","BK4139","IE00B19Z9Z06.USD","IE00BFTCPJ56.SGD","LU0109394709.USD","LU1430594728.SGD","LU0234570918.USD","IE00B894F039.SGD","CRSP","LU0058720904.USD","IE0009355771.USD","LU2237438978.USD","LU0320765992.SGD","LU2362541513.USD","VRTX","BK4023","BK4533","IE00B19Z9P08.USD","LU0289739699.SGD","LU0256863811.USD","BK4556","BK4585","LU1035775433.USD","IE00B19Z3B42.SGD","BK4588","IE0002270589.USD","LU0061475181.USD","IE00BJJMRZ35.SGD","IE00BZ9MQY76.HKD","LU1069344957.HKD","LU1585245621.USD","LU0079474960.USD","LU1093756325.SGD","LU0889565916.HKD","LU2362541273.HKD","LU2324357040.USD"],"gpt_icon":0},{"id":"2457406282","title":"CRISPR Therapeutics AG: RBC将目标价下调至60美元下调前为66美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2457406282","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457406282?lang=zh_cn&edition=full","pubTime":"2024-08-06 14:31","pubTimestamp":1722925872,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4139","BK4556","AG","BK4585","BK4210","LU1861559042.SGD","CRSP","BK4588","LU1861558580.USD","LENZ"],"gpt_icon":0},{"id":"2457775333","title":"Crispr Therapeutics Ag盘中异动 大幅下挫12.17%报44.89美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457775333","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457775333?lang=zh_cn&edition=full","pubTime":"2024-08-05 21:30","pubTimestamp":1722864625,"startTime":"0","endTime":"0","summary":"北京时间2024年08月05日21时30分，Crispr Therapeutics Ag股票出现异动，股价快速下挫12.17%。截至发稿，该股报44.89美元/股，成交量7.8957万股，换手率0.09%，振幅0.00%。Crispr Therapeutics Ag股票所在的生物技术行业中，整体跌幅为1.55%。Crispr Therapeutics Ag公司简介：Crispr Therapeutics是一家基因编辑公司，专注于开发基于CRISPR/Cas9的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805213025aefd4b85&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805213025aefd4b85&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","BK4556","BK4585","BK4588","CRSP","LU1861559042.SGD","LU1861558580.USD"],"gpt_icon":0},{"id":"2456065289","title":"Crispr Therapeutics Ag盘中异动 早盘股价大跌5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2456065289","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456065289?lang=zh_cn&edition=full","pubTime":"2024-08-02 21:34","pubTimestamp":1722605670,"startTime":"0","endTime":"0","summary":"北京时间2024年08月02日21时34分，Crispr Therapeutics Ag股票出现波动，股价大幅下跌5.22%。Crispr Therapeutics Ag股票所在的生物技术行业中，整体跌幅为0.59%。其相关个股中，Exicure, Inc.、Dermata Therapeutics, Inc.、Os Therapies Incorporated涨幅较大，Exicure, Inc.、Dermata Therapeutics, Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为352.96%、131.60%、21.99%，振幅较大的相关个股有Exicure, Inc.、Dermata Therapeutics, Inc.、Anew Medical Inc C/Wts 21/06/2029 ，振幅分别为33.34%、26.61%、17.87%。Crispr Therapeutics Ag公司简介：Crispr Therapeutics是一家基因编辑公司，专注于开发基于CRISPR/Cas9的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080221343096823405&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080221343096823405&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LU1861558580.USD","LU1861559042.SGD","BK4588","BK4585","CRSP","BK4556","LENZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.crisprtx.com","stockEarnings":[{"period":"1week","weight":-0.012},{"period":"1month","weight":-0.0364},{"period":"3month","weight":-0.0493},{"period":"6month","weight":-0.162},{"period":"1year","weight":-0.3433},{"period":"ytd","weight":-0.2605}],"compareEarnings":[{"period":"1week","weight":0.0005},{"period":"1month","weight":0.0177},{"period":"3month","weight":0.0561},{"period":"6month","weight":0.1213},{"period":"1year","weight":0.3047},{"period":"ytd","weight":0.249}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"CRISPR Therapeutics AG作为一家瑞士股份公司在Inception Genomics AG名下于2013年10月31日注册成立。他们是一家领先的基因研究的公司，专注于CRISPR/Cas9的疗法发展。 CRISPR/ Cas9代表集群，定期相互间隔短回文重复（CRISPR）相关蛋白9，是改变基因的编排，基因组DNA的特定序列过程中的一项革命性的技术。他们正在应用此技术通过破坏，纠正或调节与疾病相关的基因来治疗广泛的稀有或常见的疾病。他们最先进的项目是针对β-地中海贫血和镰状细胞病，这种病症的治疗需要两个满足高医疗需求的血红蛋白。","yearOnYearQuotes":[{"month":1,"riseRate":0.625,"avgChangeRate":0.090159},{"month":2,"riseRate":0.625,"avgChangeRate":0.089566},{"month":3,"riseRate":0.25,"avgChangeRate":-0.077241},{"month":4,"riseRate":0.625,"avgChangeRate":-0.022564},{"month":5,"riseRate":0.625,"avgChangeRate":0.107663},{"month":6,"riseRate":0.75,"avgChangeRate":0.098677},{"month":7,"riseRate":0.75,"avgChangeRate":0.025869},{"month":8,"riseRate":0.5,"avgChangeRate":-0.003893},{"month":9,"riseRate":0.125,"avgChangeRate":-0.096371},{"month":10,"riseRate":0.375,"avgChangeRate":-0.049057},{"month":11,"riseRate":0.666667,"avgChangeRate":0.198619},{"month":12,"riseRate":0.25,"avgChangeRate":-0.050604}],"exchange":"NASDAQ","name":"CRISPR Therapeutics AG","nameEN":"CRISPR Therapeutics AG"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"CRISPR Therapeutics AG(CRSP)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供CRISPR Therapeutics AG(CRSP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"CRISPR Therapeutics AG,CRSP,CRISPR Therapeutics AG股票,CRISPR Therapeutics AG股票老虎,CRISPR Therapeutics AG股票老虎国际,CRISPR Therapeutics AG行情,CRISPR Therapeutics AG股票行情,CRISPR Therapeutics AG股价,CRISPR Therapeutics AG股市,CRISPR Therapeutics AG股票价格,CRISPR Therapeutics AG股票交易,CRISPR Therapeutics AG股票购买,CRISPR Therapeutics AG股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"CRISPR Therapeutics AG(CRSP)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供CRISPR Therapeutics AG(CRSP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}